Concepedia

Erin Cebula

EC

Statistics

Publications

3

Citations

363

H-Index

3

Active since

2013

Affiliations

University of Rochester(Current)

Erin Cebula is an author at University of Rochester specializing in pathology, medicine, and radiation oncology.

Top concepts

Publications per year

2013–2015

3

Publications

3

Phase II Study of Alisertib, a Selective Aurora A Kinase Inhibitor, in Relapsed and Refractory Aggressive B- and T-Cell Non-Hodgkin Lymphomas

Jonathan W. Friedberg, Daruka Mahadevan, Erin Cebula et al. · Journal of Clinical Oncology · 2013 · 208 citations · Full text

A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213

Steven H. Bernstein, Elliot Epner, Joseph M. Unger et al. · Annals of Oncology · 2013 · 133 citations · Full text

, , +7

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas

Beata Holkova, Maciej Kmieciak, Prithviraj Bose et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 22 citations · Full text

, , +18

1–3 of 3